Amphastar Pharmaceuticals, Inc. (AMPH) vs Cronos Group Inc. (CRON)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- Cronos Group Inc. CRON 3.22 +0.63%
Amphastar Pharmaceuticals, Inc. and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. Amphastar Pharmaceuticals, Inc. and Cronos Group Inc. are of similar size ($1.2B and $1.1B). Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 16.1×. Cronos Group Inc. grew revenue faster over the last twelve months: 37.5% against 1.02%. Cronos Group Inc. has the higher net margin (20.9% vs 10.8%) and the lower return on invested capital (−0.34% vs 6.57%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 15 and Cronos Group Inc. on 7.
Valuation
Profitability
| Metric | AMPH | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 45.86% | 53.94% |
| Operating margin | 15.66% | (0.96%) | 0.00% |
| Net margin | 10.76% | 20.91% | 0.00% |
| Free cash flow margin | 20.94% | 27.61% | 0.00% |
| Return on equity | 10.30% | 3.33% | (0.40%) |
| Return on assets | 4.68% | 3.18% | (3.32%) |
| Return on invested capital | 6.57% | (0.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack